United States · FDA National Drug Code directory
Conjupri
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 24075-0413_22836378-d73e-4b0b-88bb-b82dd3420aab
- Product NDC
- 24075-0413
- Form
- TABLET
- Composition / generic term
- levamlodipine
- Labeler
- CSPC Ouyi Pharmaceutical Co. Ltd
- Marketing category
- NDA
- Marketing start / end (source format)
- 20211008
- Source listing expiry
- 20261231
Source-listed ingredients
- LEVAMLODIPINE MALEATE — 5 mg/5mg
These values do not establish equivalence or a dose recommendation.
Packages
- 5 mg in 1 BOTTLE (24075-0413-3) · 24075-0413-3
- 5 mg in 1 BOTTLE (24075-0413-5) · 24075-0413-5
- 5 mg in 1 BOTTLE (24075-0413-9) · 24075-0413-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →